Texas 2025 89th Regular

Texas Senate Bill SB883 Fiscal Note / Fiscal Note

Filed 03/30/2025

                    LEGISLATIVE BUDGET BOARD     Austin, Texas       FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION             March 30, 2025       TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: SB883 by Paxton (Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.), As Introduced     No significant fiscal implication to the State is anticipated. It is assumed that any costs associated with the bill could be absorbed using existing resources.  Local Government ImpactNo fiscal implication to units of local government is anticipated.  Source Agencies: b > td > 503 Texas Medical Board  LBB Staff: b > td > JMc, NPe, BFa

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION
March 30, 2025

 

 

  TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: SB883 by Paxton (Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.), As Introduced   

TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: SB883 by Paxton (Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.), As Introduced

 Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services

 Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services

 Jerry McGinty, Director, Legislative Budget Board 

 Jerry McGinty, Director, Legislative Budget Board 

 SB883 by Paxton (Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.), As Introduced 

 SB883 by Paxton (Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.), As Introduced 



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.

It is assumed that any costs associated with the bill could be absorbed using existing resources.

 Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies: b > td > 503 Texas Medical Board

503 Texas Medical Board

LBB Staff: b > td > JMc, NPe, BFa

JMc, NPe, BFa